J. Slattery

发表

Cyclophosphamide metabolism is affected by azole antifungals.

W. Leisenring, M. Boeckh, L. Corey, 2004, Blood.

Respiratory effects of intravenous morphine infusions in neonates, infants, and children after cardiac surgery.

J. Slattery, K. Opheim, A. Lynn, 1993, Anesthesia and analgesia.

Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial.

Neil Kaplowitz, Paul B Watkins, P. Watkins, 2006, JAMA.

The Road We Must Take: Multidisciplinary Team Science

John T. Slattery, M. Disis, J. Slattery, 2010, Science Translational Medicine.

Car unlikely to significantly modulate acetaminophen hepatotoxicity in most humans

P. Watkins, S. Nelson, K. Thummel, 2003 .

Morphine Pharmacokinetics in Early Infancy

J. Slattery, A. Lynn, 1987, Anesthesiology.

The maturation of morphine clearance and metabolism.

J. Slattery, K. Opheim, A. Lynn, 1992, American journal of diseases of children.

A pharmacokinetic model-independent approach for estimating dose required to give desired steady-state trough concentrations of drug in plasma

J. Slattery, 1980, Journal of Pharmacokinetics and Biopharmaceutics.

Disposition of Acetaminophen at 4, 6, and 8 g/day for 3 Days in Healthy Young Adults

J. Slattery, C. Gelotte, A. R. Temple, 2007, Clinical pharmacology and therapeutics.

The effect of omeprazole pretreatment on acetaminophen metabolism in rapid and slow metabolizers of S‐mephenytoin

James M. Wright, S. Nelson, S. Adams, 1997 .

The impact of obesity and disease on busulfan oral clearance in adults.

F. Appelbaum, T. Gooley, J. Gibbs, 1999, Blood.

Correction for bacterial loss in in vitro dilution models

A. Smith, J. Slattery, C. White, 1987, Antimicrobial Agents and Chemotherapy.

malignancies nonmyeloablative conditioning for patients with hematologic HLA-matched unrelated donor hematopoietic cell transplantation after

S. Heimfeld, M. Maris, B. Sandmaier, 2013 .

ABCC2-Mediated Biliary Transport of 4-Glutathionylcyclophosphamide and Its Contribution to Elimination of 4-Hydroxycyclophosphamide in Rat

J. Slattery, T. Kalhorn, R. Qiu, 2004, Journal of Pharmacology and Experimental Therapeutics.

Pharmacological considerations of primary alkylators.

J. McCune, J. Slattery, 2002, Cancer treatment and research.

Disposition of drugs in cystic fibrosis. III. Acetaminophen

A. Smith, Arnold L. Smith, J. Unadkat, 1991, Clinical pharmacology and therapeutics.

Absorption of diazepam and lorazepam following intranasal administration

S. Lau, J. Slattery, 1989 .

The formation and toxicity of catechol metabolites of acetaminophen in mice.

J. Wilson, S. Nelson, J. Slattery, 1984, Drug metabolism and disposition: the biological fate of chemicals.

Overexpression of glutathione-S-transferase, MGSTII, confers resistance to busulfan and melphalan.

H. Kiem, J. Slattery, M. Harkey, 2005, Cancer investigation.

Comparison of human liver and small intestinal glutathione S-transferase-catalyzed busulfan conjugation in vitro.

J. Gibbs, J. Slattery, J. Yang, 1998, Drug metabolism and disposition: the biological fate of chemicals.

Effect of treatment with phenobarbital and stiripentol on carbamazepine-induced teratogenicity and reactive metabolite formation.

G. Bennett, R. Finnell, J. Slattery, 1995, Teratology.

Lack of effect of cimetidine on acetaminophen disposition in humans

E. Kharasch, J. Slattery, A. C. Eddy, 1989, Clinical pharmacology and therapeutics.

Overexpression of Glutathione-S-Transferase, MGSTII, Confers Resistance to Busulfan and Melphalan

H. Kiem, J. Slattery, M. Harkey, 2005 .

Human CD34+ cells do not express glutathione S-transferases alpha

H. Kiem, J. Slattery, M. Czerwiński, 1997, Gene Therapy.

Metabolism‐based cyclophosphamide dosing for hematopoietic cell transplant

Brian R. Phillips, P. Vicini, G. McDonald, 2005, Clinical pharmacology and therapeutics.

Busulfan-glutathione conjugation catalyzed by human liver cytosolic glutathione S-transferases.

J. Gibbs, J. Slattery, M. Czerwiński, 1996, Cancer research.

Acetaminophen kinetics in acutely poisoned patients

J. Slattery, G. Levy, 1979, Clinical pharmacology and therapeutics.

Phase I topotecan preparative regimen for high-risk neuroblastoma, high-grade glioma, and refractory/recurrent pediatric solid tumors.

K. Matthay, D. Hawkins, T. Gooley, 2000, Medical and Pediatric Oncology.

Metabolic activation of (R)-(+)-pulegone to a reactive enonal that covalently binds to mouse liver proteins.

S. Nelson, J. Slattery, R. Mcclanahan, 1989, Chemical research in toxicology.

Partial characterization of biliary metabolites of pulegone by tandem mass spectrometry. Detection of glucuronide, glutathione, and glutathionyl glucuronide conjugates.

P. Pearson, S. Nelson, J. Slattery, 1991, Drug metabolism and disposition: the biological fate of chemicals.

Contribution of menthofuran to the hepatotoxicity of pulegone: assessment based on matched area under the curve and on matched time course.

S. Nelson, J. Slattery, D. Thomassen, 1988, The Journal of pharmacology and experimental therapeutics.

Reactive intermediates in the oxidation of menthofuran by cytochromes P-450.

N. Knebel, S. Nelson, J. Slattery, 1992, Chemical research in toxicology.

Menthofuran-dependent and independent aspects of pulegone hepatotoxicity: roles of glutathione.

S. Nelson, J. Slattery, D. Thomassen, 1990, The Journal of pharmacology and experimental therapeutics.

Saturable Tissue Binding and Imirestat Pharmacokinetics in Rats

J. Chien, C. Banfield, J. Slattery, 1992, Pharmaceutical Research.

Dose-Dependent Pharmacokinetics of the Aldose Reductase Inhibitor Imirestat in Man

P. McNamara, J. Slattery, R. Dobbs, 2004, Pharmaceutical Research.

A highly sensitive high-performance liquid chromatography-mass spectrometry method for quantification of fludarabine triphosphate in leukemic cells.

Joanne Wang, J. McCune, J. Slattery, 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Effects of caffeine and theophylline on acetaminophen pharmacokinetics: P450 inhibition and activation.

S. Nelson, J. Slattery, C. Lee, 1996, The Journal of pharmacology and experimental therapeutics.

Allogeneic hematopoietic stem cell transplantation for myelofibrosis.

H. Deeg, J. Radich, R. Storb, 2003, Blood.

single-center study disease after marrow transplantation from HLA-matched siblings: a methylprednisolone for the prevention of acute graft-versus-host Tacrolimus (FK506) alone or in combination with methotrexate or

Ruth Etzioni, R. Storb, R. Nash, 2011 .

Effect of halothane-oxygen anesthesia on the pharmacokinetics of diazepam and its metabolites in rats.

J. Slattery, D. Calkins, L. E. Bell, 1985, The Journal of pharmacology and experimental therapeutics.

Diminishing the risk of nonrelapse mortality in hematopoietic stem cell transplantation: Prediction of exposure to the cyclophosphamide metabolite Carboxyethylphosphoramide mustard

P. Vicini, G. McDonald, J. Slattery, 2004, Clinical pharmacology and therapeutics.

Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation.

M. Maris, R. Storb, B. Sandmaier, 2005, Blood.

Dose Escalation of Busulfan with Pentoxifylline and Ciprofloxacin in Patients with Breast Cancer Undergoing Autologous Transplants

R. Storb, J. Slattery, W. Bensinger, 2005, Oncology.

Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation.

T. Gooley, C. Anasetti, G. McDonald, 2003, Blood.

hematopoietic stem cell transplantation Cyclophosphamide metabolism , liver toxicity , and mortality following

T. Gooley, C. Anasetti, G. McDonald, 2002 .

Inhibition of sulfamethoxazole hydroxylamine formation by fluconazole in human liver microsomes and healthy volunteers

E. Kharasch, J. Unadkat, K. Thummel, 1996, Clinical pharmacology and therapeutics.

Differences in the protein binding of several drugs and bilirubin in serum and heparinized plasma of rats.

J. Slattery, G. Levy, U. Wiegand, 1979, Life sciences.

Allogeneic hematopoietic stem cell transplantation for myeloﬁbrosis

H. Deeg, J. Radich, R. Storb, 2003 .

Rapid quantitation of cyclophosphamide metabolites in plasma by liquid chromatography-mass spectrometry.

Brian R. Phillips, W. Howald, Joanne Wang, 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells.

H. Deeg, J. Radich, B. Storer, 2003, Blood.

Influence of polymorphic N‐acetyltransferase phenotype on the inhibition and induction of acetaminophen bioactivation with long‐term isoniazid

J. Chien, R. Peter, S. Nelson, 1997, Clinical pharmacology and therapeutics.

Effect of sodium sulfate on acetaminophen elimination by rats.

J. Slattery, G. Levy, R. Galinsky, 1979, Journal of pharmaceutical sciences.

Reduction of acetaminophen toxicity by sodium sulfate in mice.

J. Slattery, G. Levy, 1977, Research communications in chemical pathology and pharmacology.

Plasma Concentration Monitoring of Busulfan

J. Gibbs, J. McCune, J. Slattery, 2000 .

Real-time Dose Adjustment of Cyclophosphamide in a Preparative Regimen for Hematopoietic Cell Transplant: A Bayesian Pharmacokinetic Approach

Brian R. Phillips, D. Salinger, P. Vicini, 2006, Clinical Cancer Research.

allogeneic hematopoietic stem cells Conditioning with fludarabine and targeted busulfan for transplantation of

J. Radich, B. Storer, F. Appelbaum, 2013 .

Inhibition of carboxyethylphosphoramide mustard formation from 4-hydroxycyclophosphamide by carmustine

J. Slattery, S. Ren, 1999, AAPS PharmSci.

HALOTHANE INHIBITS OXIDATIVE DRUG METABOLISM IN INTACT RATS

J. Slattery, L. E. Bell, L. Bell, 1984 .

Prediction of Maintenance Dose Required to Attain a Desired Drug Concentration at Steady-state From a Single Determination of Concentration After an Initial Dose

M. Gibaldi, J. Slattery, J. R. Koup, 1980, Clinical pharmacokinetics.

Mechanism of cytochrome P450 activation by caffeine and 7,8-benzoflavone in rat liver microsomes.

S. Nelson, K. Thummel, J. Slattery, 1997, Drug metabolism and disposition: the biological fate of chemicals.

Propranolol reduces bupivacaine clearance.

T. A. Bowdle, J. Slattery, P. Freund, 1987, Anesthesiology.

Age-dependent Lidocaine Pharmacokinetics During Lumbar Peridural Anesthesia with Lidocaine Hydrocarbonate or Lidocaine Hydrochloride

A. Bowdle, J. Slattery, P. Freund, 1986, Regional Anesthesia & Pain Medicine.

Metabolism of lisofylline and pentoxifylline in human liver microsomes and cytosol.

J. Slattery, T. Kalhorn, J. A. Lillibridge, 1996, Drug metabolism and disposition: the biological fate of chemicals.

Analysis of oxidized and reduced pyridine dinucleotides in rat liver by high-performance liquid chromatography.

S. Nelson, K. Thummel, J. Slattery, 1985, Analytical biochemistry.

Analysis of acetaminophen metabolites in urine by high-performance liquid chromatography with UV and amperometric detection.

J. Wilson, S. Nelson, J. Slattery, 1982, Journal of chromatography.

Inhibition of the metabolism of paracetamol by isoniazid.

M. Epstein, S. Nelson, J. Slattery, 1991, British journal of clinical pharmacology.

Inhibition ofthemetabolism ofparacetamol byisoniazid

M. Epstein, S. Nelson, J. Slattery, 1991 .

Up-regulation of glutathione S-transferase activity in enterocytes of young children.

R. Baldassano, J. Gibbs, J. Slattery, 1999, Drug metabolism and disposition: the biological fate of chemicals.

Age-dependent tetrahydrothiophenium ion formation in young children and adults receiving high-dose busulfan.

J. Chien, J. Gibbs, J. Slattery, 1997, Cancer research.

Haemoperfusion in the Management of Digoxin Toxicity: Is it Warranted?

J. Slattery, J. Koup, Jeffrey R. Koup, 1979, Clinical pharmacokinetics.

Acetaminophen pharmacokinetics after overdose.

J. Slattery, J. Koup, G. Levy, 1981, Clinical toxicology.

Oxidation of cyclophosphamide to 4-hydroxycyclophosphamide and deschloroethylcyclophosphamide in human liver microsomes.

J. Slattery, T. Kalhorn, J. Yang, 1997, Cancer research.

Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults

P. Watkins, J. Chien, S. Nelson, 2000, Clinical pharmacology and therapeutics.

Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation

E. Kharasch, J. Slattery, Peter T. Manyike, 2000, Clinical pharmacology and therapeutics.

Pharmacokinetic consequences of induction of CYP2E1 by ligand stabilization.

J T Slattery, J. Chien, K. Thummel, 1997, Drug metabolism and disposition: the biological fate of chemicals.

The effect of omeprazole pretreatment on acetaminophen metabolism in rapid and slow metabolizers of S‐mephenytoin

S. Adams, J. Slattery, S. Magee, 1997, Clinical pharmacology and therapeutics.

The complex interaction between ethanol and acetaminophen

S. Nelson, K. Thummel, J. Slattery, 1996, Clinical pharmacology and therapeutics.

Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis.

S. Nelson, C. Nolan, K. Thummel, 1994, Chest.

Teratogenicity of carbamazepine-10, 11-epoxide and oxcarbazepine in the SWV mouse.

B. Wlodarczyk, G. Bennett, R. Finnell, 1996, The Journal of pharmacology and experimental therapeutics.

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies.

S. Heimfeld, M. Maris, R. Storb, 2003, Blood.

Inhibition and induction of cytochrome P4502E1‐catalyzed oxidation by isoniazid in humans

S. Nelson, S. Adams, K. Thummel, 1993, Clinical pharmacology and therapeutics.

The effect of clarithromycin, fluconazole, and rifabutin on sulfamethoxazole hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283)

J. Unadkat, T. Hooton, J. Slattery, 2004, Clinical pharmacology and therapeutics.

Characterization of carbamazepine metabolism in a mouse model of carbamazepine teratogenicity.

G. Bennett, R. Finnell, S. Nelson, 1997, Drug metabolism and disposition: the biological fate of chemicals.

MECHANISM OF CYTOCHROME P 450 ACTIVATION BY CAFFEINE AND 7 , 8-BENZOFLAVONE IN RAT LIVER MICROSOMES

Caroline A. Lee, S. Nelson, K. Thummel, 1997 .

Effect of thermal injury on the pharmacokinetics and pharmacodynamics of atracurium in humans.

D. Heimbach, R. Haschke, J. Slattery, 1989, Anesthesiology.

Large Burns Magnify and Prolong Increases in Acetylcholine Receptors and Resistance to Nondepolarizing Muscle Relaxants in Muscle under Burned Skin in Rats

J. Slattery, E. Pavlin, M. Howard, 1994 .

Acetylcholine receptor density and acetylcholinesterase activity in skeletal muscle of rats following thermal injury.

R. Haschke, J. Slattery, E. Pavlin, 1989, Anesthesiology.

RESISTANCE TO ATRACURIUM IN THERMALLY INJURED RATS

R. Haschke, J. Slattery, P. Karnik, 1986 .

Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4.

S. Nelson, K. Thummel, J. Slattery, 1993, Biochemical pharmacology.

Accumulation kinetics of drugs with nonlinear plasma protein and tissue binding characteristics

P. McNamara, M. Gibaldi, J. Slattery, 1979, Journal of Pharmacokinetics and Biopharmaceutics.

RESISTANCE TO ATRACURIUM IN MUSCLES UNDER THERMALLY INJURED SKIN IN THE RAT

J. Slattery, E. Pavlin, M. Howard, 1991 .

Pharmacokinetics of cyclophosphamide and its metabolites in bone marrow transplantation patients

F. Appelbaum, C. Anasetti, G. McDonald, 1998, Clinical pharmacology and therapeutics.

A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease.

Paul Martin, Lawrence Corey, H. Deeg, 2002, Blood.

Inhibition of human aldehyde dehydrogenase 1 by the 4-hydroxycyclophosphamide degradation product acrolein.

J. Slattery, T. Kalhorn, S. Ren, 1999, Drug metabolism and disposition: the biological fate of chemicals.

A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation.

H. Deeg, R. Storb, B. Storer, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

J. Radich, F. Appelbaum, M. Flowers, 2003, Blood.

Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.

H. Deeg, J. Radich, R. Storb, 2002, Blood.

Comparative pharmacokinetics of coumarin anticoagulants. XLVI: Effect of treatment of phenobarbital on pharmacokinetics of (S)-(-)-warfarin in rats.

A Yacobi, G Levy, J T Slattery, 1980, Journal of pharmaceutical sciences.

Comparative pharmacokinetics of coumarin anticoagulants XXIV: Effect of treatment with phenobarbital on serum protein binding of warfarin and dicumarol in rats.

J. Slattery, A. Yacobi, G. Levy, 1977, Journal of pharmaceutical sciences.

Comparative pharmacokinetics of coumarin anticoagulants XXV: Warfarin-ibuprofen interaction in rats.

J. Slattery, A. Yacobi, G. Levy, 1977, Journal of pharmaceutical sciences.

Analysis of cyclophosphamide and five metabolites from human plasma using liquid chromatography-mass spectrometry and gas chromatography-nitrogen-phosphorus detection.

W. Howald, J. Slattery, T. Kalhorn, 1999, Journal of chromatography. B, Biomedical sciences and applications.

Plasma concentration monitoring of busulfan: does it improve clinical outcome?

J. Gibbs, J. McCune, J. Slattery, 2000, Clinical pharmacokinetics.

Busulfan conjugation by glutathione S-transferases alpha, mu, and pi.

J. Gibbs, J. Slattery, M. Czerwiński, 1996, Drug metabolism and disposition: the biological fate of chemicals.

Persistence of antifolate activity in skin of rats following systemic administration of methotrexate.

T. Franz, J. Slattery, C. Zimmerman, 1984, The Journal of investigative dermatology.

Targeted Busulfan and Cyclophosphamide as Compared to Busulfan and TBI as Preparative Regimens for Transplantation in Patients with Advanced MDS or Transformation to AML

H. Deeg, B. Storer, F. Appelbaum, 2004, Leukemia & lymphoma.

Real-time DoseAdjustment of Cyclophosphamide in a Preparative Regimen for Hematopoietic CellTransplant : ABayesian Pharmacokinetic Approach

Brian R. Phillips, D. Salinger, D. Shen, 2006 .

Effect of ibuprofen on protein binding of warfarin in human serum.

J. Slattery, G. Levy, 1977, Journal of pharmaceutical sciences.

Pharmacokinetic model of acetaminophen elimination.

J. Slattery, G. Levy, Gerhard Levy, 1979, American journal of hospital pharmacy.

Plasma Concentration Monitoring of BusulfanIt Improve Clinical Outcome

J. Gibbs, J. McCune, J. Slattery, 2000 .

Selective mitochondrial glutathione depletion by ethanol enhances acetaminophen toxicity in rat liver

P. Zhao, J. Slattery, T. Kalhorn, 2002, Hepatology.

The impact of obesity and disease on busulfan oral clearance in adults

F. Appelbaum, T. Gooley, J. Gibbs, 1999 .

Pharmacokinetics of the poly-gamma-glutamyl metabolites of methotrexate in skin and other tissues of rats and hairless mice.

T. Franz, J. Slattery, C. Zimmerman, 1984, The Journal of pharmacology and experimental therapeutics.

Transiently altered acetaminophen metabolism after liver transplantation

M. Hebert, Yvonne S. Lin, C. Marsh, 2003, Clinical pharmacology and therapeutics.

Multimodal distribution of warfarin binding to protein in serum of male-Sprague Dawley rats.

J. Slattery, A. Yacobi, G. Levy, 1976, Life sciences.

In vitro evaluation of the determinants of bactericidal activity of ampicillin dosing regimens against Escherichia coli

A. Smith, J. Slattery, C. White, 1989, Antimicrobial Agents and Chemotherapy.

Percutaneous absorption of retinoids: influence of vehicle, light exposure, and dose.

T. Franz, J. Slattery, P. Lehman, 1988, The Journal of investigative dermatology.

Cytochrome P450 isozymes involved in lisofylline metabolism to pentoxifylline in human liver microsomes.

J. Slattery, S. Lee, 1997, Drug metabolism and disposition: the biological fate of chemicals.

Maintenance-dose prediction based on a single determination of concentration: general applicability to two-compartment drugs with reference to lithium.

J. Slattery, C. Zimmerman, 1983, Journal of pharmaceutical sciences.

Procoagulant effect of phenobarbital in rats.

J. Slattery, A. Yacobi, G. Levy, 1980, Life sciences.

Effects of food, mild stress, and distributed intake on the absorption and plasma concentration-time profile of orally ingested ethanol in pigtailed macaques

D. Bowden, J. Slattery, T. Kalhorn, 1986, Pharmacology Biochemistry and Behavior.

Determination of naproxen and its desmethyl metabolite in human plasma or serum by high performance liquid chromatography.

J. Slattery, G. Levy, 1979, Clinical biochemistry.

Dose‐dependent pharmacokinetics of acetaminophen: Evidence of glutathione depletion in humans

J T Slattery, S. Nelson, J. Slattery, 1987, Clinical pharmacology and therapeutics.

Effect of liposome dose on the elimination of small unilamellar sphingomyelin/cholesterol vesicles from the circulation.

P. Beaumier, J. Slattery, K. Hwang, 1983, Research communications in chemical pathology and pharmacology.

Protein binding of several drugs in serum and plasma of healthy subjects

J. Slattery, G. Levy, U. Wiegand, 1980, Clinical pharmacology and therapeutics.

Maintenance-dose prediction based on a single determination of concentration: dose of parent drug required to give a desired steady-state concentration of metabolite.

J. Wilson, J. Slattery, 1983, Journal of pharmaceutical sciences.

Single-point maintenance dose prediction: role of interindividual differences in clearance and volume of distribution in choice of sampling time.

J. Slattery, 1981, Journal of pharmaceutical sciences.

Single point clearance estimation.

M. Gibaldi, J. Slattery, J. Koup, 1979, Research communications in chemical pathology and pharmacology.

Protein-reactive metabolites of carbamazepine in mouse liver microsomes.

G. Bennett, R. Finnell, S. Nelson, 1996, Drug metabolism and disposition: the biological fate of chemicals.

Effect of methylxanthines on acetaminophen hepatotoxicity in various induction states.

S. Nelson, J. Slattery, T. Kalhorn, 1990, The Journal of pharmacology and experimental therapeutics.

Age-dependent morphine partitioning between plasma and cerebrospinal fluid in monkeys.

J. Slattery, K. Opheim, A. Lynn, 1991, Developmental pharmacology and therapeutics.

Effect of ethanol on hepatotoxicity of acetaminophen in mice and on reactive metabolite formation by mouse and human liver microsomes.

P. Pearson, S. Nelson, K. Thummel, 1989, Toxicology and applied pharmacology.

Mechanism by which ethanol diminishes the hepatotoxicity of acetaminophen.

S. Nelson, K. Thummel, J. Slattery, 1988, The Journal of pharmacology and experimental therapeutics.

Pharmacokinetics of ethanol in pigtailed macaques: Intersubject variability and effect of subchronic administration

D. Bowden, J. Slattery, T. Kalhorn, 1986, Pharmacology Biochemistry and Behavior.

Re: intravenous versus oral busulfan--perhaps not as different as suggested.

J. Slattery, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Mupirocin resistance in Staphylococcus aureus in Western Australia

T. Riley, J. Slattery, W. Grubb, 1995 .

PHARHACOKINETICS OF MORPHINE SULFATE IN EARLY INFANCY

J. Slattery, A. Lynn, 1985 .

Effects of ethanol dose and ethanol withdrawal on rat liver mitochondrial glutathione: implication of potentiated acetaminophen toxicity in alcoholics.

P. Zhao, J. Slattery, 2002, Drug metabolism and disposition: the biological fate of chemicals.

The effect of clarithromycin, fluconazole, and rifabutin on dapsone hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283)

J. Unadkat, T. Hooton, J. Slattery, 2004, Clinical pharmacology and therapeutics.

CYP3A4-mediated oxidation of lisofylline to lisofylline 4,5-diol in human liver microsomes.

J. Slattery, H. Shin, 1998, Journal of pharmaceutical sciences.

Caudal Anesthesia with Lidocaine or Bupivacaine: Plasma Local Anesthetic Concentration and Extent of Sensory Spread in Old and Young Patients

T. A. Bowdle, J. Slattery, P. Freund, 1984, Anesthesia and analgesia.

Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation.

H. Deeg, K. Sullivan, R. Storb, 1997, Blood.

Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age.

H. Deeg, R. Storb, F. Appelbaum, 2000, Blood.

Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.

H. Deeg, J. Radich, R. Storb, 2002, Blood.

Effect of naproxen on the kinetics of elimination and anticoagulant activity of a single dose of warfarin

Adesh K. Jain, F. Mcmahon, J. Slattery, 1979, Clinical pharmacology and therapeutics.